APRE
Price
$1.71
Change
+$0.04 (+2.40%)
Updated
Jun 30, 12:44 PM (EDT)
Capitalization
9.27M
CABA
Price
$1.55
Change
-$0.02 (-1.27%)
Updated
Jun 30, 12:55 PM (EDT)
Capitalization
142.94M
38 days until earnings call
Interact to see
Advertisement

APRE vs CABA

Header iconAPRE vs CABA Comparison
Open Charts APRE vs CABABanner chart's image
Aprea Therapeutics
Price$1.71
Change+$0.04 (+2.40%)
Volume$100
Capitalization9.27M
Cabaletta Bio
Price$1.55
Change-$0.02 (-1.27%)
Volume$1.11K
Capitalization142.94M
APRE vs CABA Comparison Chart in %
Loading...
APRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CABA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APRE vs. CABA commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APRE is a Buy and CABA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (APRE: $1.67 vs. CABA: $1.57)
Brand notoriety: APRE and CABA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APRE: 136% vs. CABA: 346%
Market capitalization -- APRE: $9.27M vs. CABA: $142.94M
APRE [@Biotechnology] is valued at $9.27M. CABA’s [@Biotechnology] market capitalization is $142.94M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APRE’s FA Score shows that 2 FA rating(s) are green whileCABA’s FA Score has 1 green FA rating(s).

  • APRE’s FA Score: 2 green, 3 red.
  • CABA’s FA Score: 1 green, 4 red.
According to our system of comparison, APRE is a better buy in the long-term than CABA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APRE’s TA Score shows that 5 TA indicator(s) are bullish while CABA’s TA Score has 3 bullish TA indicator(s).

  • APRE’s TA Score: 5 bullish, 4 bearish.
  • CABA’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, APRE is a better buy in the short-term than CABA.

Price Growth

APRE (@Biotechnology) experienced а +2.45% price change this week, while CABA (@Biotechnology) price change was -12.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.10%. For the same industry, the average monthly price growth was +33.47%, and the average quarterly price growth was +7.38%.

Reported Earning Dates

APRE is expected to report earnings on May 14, 2025.

CABA is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.10% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CABA($143M) has a higher market cap than APRE($9.27M). CABA YTD gains are higher at: -30.837 vs. APRE (-49.088). APRE has higher annual earnings (EBITDA): -15.23M vs. CABA (-123.92M). CABA has more cash in the bank: 132M vs. APRE (19.3M). APRE has less debt than CABA: APRE (0) vs CABA (28.8M). APRE (0) and CABA (0) have equivalent revenues.
APRECABAAPRE / CABA
Capitalization9.27M143M6%
EBITDA-15.23M-123.92M12%
Gain YTD-49.088-30.837159%
P/E RatioN/AN/A-
Revenue00-
Total Cash19.3M132M15%
Total Debt028.8M-
TECHNICAL ANALYSIS
Technical Analysis
APRECABA
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
78%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
86%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
79%
Bearish Trend 4 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
88%
Advances
ODDS (%)
Bullish Trend 6 days ago
77%
Bullish Trend 18 days ago
88%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 4 days ago
84%
Aroon
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
APRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CABA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SNA311.011.46
+0.47%
Snap-on
HCKT25.160.02
+0.08%
Hackett Group
TELA1.85N/A
N/A
TELA Bio
KPRX2.92-0.11
-3.63%
Kiora Pharmaceuticals Inc.
UEC6.71-0.34
-4.82%
Uranium Energy Corp

APRE and

Correlation & Price change

A.I.dvisor tells us that APRE and ATOS have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that APRE and ATOS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APRE
1D Price
Change %
APRE100%
-4.42%
ATOS - APRE
32%
Poorly correlated
+0.24%
EYPT - APRE
30%
Poorly correlated
-7.04%
PRQR - APRE
30%
Poorly correlated
-5.56%
CABA - APRE
29%
Poorly correlated
-7.65%
ACET - APRE
29%
Poorly correlated
-6.71%
More

CABA and

Correlation & Price change

A.I.dvisor indicates that over the last year, CABA has been loosely correlated with IPSC. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if CABA jumps, then IPSC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CABA
1D Price
Change %
CABA100%
-7.65%
IPSC - CABA
44%
Loosely correlated
-8.62%
KYTX - CABA
43%
Loosely correlated
-5.48%
ARCT - CABA
43%
Loosely correlated
-7.49%
RNA - CABA
41%
Loosely correlated
-2.68%
OCUL - CABA
41%
Loosely correlated
-2.54%
More